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Background: Diarrhoea is the second leading cause of death in children under five accounting for 1.8 million
deaths yearly. Despite global efforts to reduce diarrhoea mortality through promotion of proper case management,
there is still room for ample improvement. In order to seek options for such improvements this study explored the
knowledge and practices of diarrhoea case management among health care providers at health centres and drug
shops in Uganda.
Methods: Records were reviewed for case management and structured interviews concerning knowledge and
practices were conducted with the staff at all health centres and at all identified drug shops in the rural district of
Namutumba, Uganda.
Results: There was a significant gap between knowledge and documented practices among staff. Antibiotics,
antimalarials and antipyretics were prescribed or recommended as frequently as Oral Rehydration Solution (ORS). In
almost a third of the health facilities, ORS was out of stock. 81% of staff in health centres and 87% of staff in drug
shops stated that they prescribed antibiotics for common diarrhoea. Zinc was not prescribed or recommended in
any case.
Conclusions: The findings indicate that many children presenting with diarrhoea are inadequately treated. As a
result they may not get the rehydration they need and are at risk of potential side effects from unjustified usage of
antibiotics. Practices must be improved at health centres and drug shops in order to reduce childhood mortality
due to diarrhoeal diseases.
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Diarrhoea is the second leading cause of under five mor-
tality globally and it accounts for 1.8 million deaths an-
nually [1]. The majority of these deaths occur in south
Asia and Africa [2]. According to Bhutta et al., child-
hood mortality has fallen by 28% since 1990 in 68 priori-
tized countries. However, efforts need to increase
substantially to achieve Millennium Development Goal 4
(MDG4) of reducing childhood deaths [3].
In order to reduce mortality and morbidity due to
childhood diarrhoea, the “Programme for Control of
Diarrhoeal Diseases” (CDD) was initiated by WHO at
the beginning of the 1980s [4]. Diarrhoea caused an esti-
mated 4.6 million deaths in children under five at that* Correspondence: Birger.Forsberg@ki.se
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reproduction in any medium, provided the ortime [5]. The major cause of death due to diarrhoeal dis-
eases is dehydration. The cornerstone in diarrhoea case
management is to prevent or treat dehydration [6]. Oral
Rehydration Therapy (ORT) was therefore chosen as the
primary intervention in the CDD programme. Subse-
quently, usage of ORT increased which contributed to
reductions in diarrhoea mortality in low- and middle-
income countries (LMIC) [7,8]. Even so, the usage of
ORT is still unsatisfactory in many LMIC [9].
In 2004, an additional therapy, zinc, was added to the
recommended treatment of diarrhoea in children. Zinc
has been found to reduce the duration and severity of
the diarrhoea episode and lower the incidence of diar-
rhoea during the months following the episode [10-12].
Later, zinc has also been shown to reduce mortality from
diarrhea [13].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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often sought from private practitioners and drug vendors
[14,15]. In many cases, an untrained drug vendor
becomes an important source of information and treat-
ment during childhood diarrhoea [16].
This study investigated knowledge and practices
among staff at health centres (HC) and drug shops (DS)
in a rural setting in Uganda in order to explore the
scope for improvement of diarrhoea case management.
Methods
Study setting
The study was carried out in Namutumba district,
located about 125 km north east of Kampala, the capital
of Uganda. This rural district had a population close to
200 000 at the time of the study. There were 33 regis-
tered HC in the district (21 governmental, 12 NGO
run). Health centres in Namutumba district range from
level two to level four. (Health facilities in Uganda are
divided into seven levels where level 1 is the village
health team, 2–4 HC, 5–6 hospitals and 7 the national
referral hospital in Kampala.) There were no pharmacies
in the district while 10 drug shops were registered with
the district headquarters.
Study participants and data collection
All registered health centres in Namutumba district were
included in the study. In each facility a structured inter-
view was carried out by the lead researcher assisted by
an interpreter. In the lower level health centres there
was typically only one staff available. When more than
one staff was present the best educated person was
interviewed. All staff approached consented to partici-
pate. In the interviews respondents’ knowledge on diar-
rhoea and diarrhoea management as well as their stated
practices were assessed. The questionnaire was con-
structed with a combination of closed and open ended
questions.
A review of the outpatient register was also done by
the lead researcher. Information about diagnosis and
recommended treatment for all cases of diarrhoea in
children under the age of five during the past two
months were recorded. A facility inventory was made in
all facilities to check for availability of ORS, drugs and
clinical guidelines.
Interviews, record reviews and inventories were con-
ducted in all but two HC that were closed at the time of
visit.
Drug shops were identified on arrival in the 24 villages
where the HC were located. All drug shops that could
be identified were visited by the research team. In most
(n = 46) of the identified DS, a structured interview was
performed by the lead researcher with the assistance of
an interpreter. In most cases there was only one personattending the DS. The design of the questionnaire was
similar to the one used in the HC. In four cases, inter-
views could not be undertaken because the staff either
declined to participate or was absent.
Data analysis
Data were entered in MS Excel 2011, cleaned for any in-
consistencies and analysed for standard distribution
measurements. Student’s two-tailed t-tests were per-
formed to determine p-values for differences between
health centres and drug shops. P-value < 0.05 was con-
sidered significant. Calculations of confidence intervals
assumed normal distribution of proportions.
Ethics
The study was approved by the Ethics Committee at
Uganda Christian University, Mukono, Uganda. All par-
ticipants gave informed consent and signed a consent
form prior to participation in the study.
Results
77% (24) of the HC visited were level two facilities, 19%
(6) level three and 3% (1) level four. The respondents in
the HC were nursing assistants (65%), nurses/midwives
(26%) or clinical officers (15%). All respondents in both
HC and DS had 3–6 years of secondary schooling and a
majority of the respondents at the HC had attended a
nursing school. The respondents at the DS were nursing
assistants (82%) or nurses/midwives (15%). One person
was a veterinary assistant (2%).
Knowledge about causes, symptoms and danger signs of
diarrhoea in children
The respondents were asked to mention causes, symp-
toms and danger signs of childhood diarrhoea. The
causes have been classified into four categories: feeding
and drinking, hygiene, microbes, and concomitant dis-
eases (table 1). The symptoms and danger signs are
divided into four categories: dehydration, gastrointes-
tinal, general condition and other. The three most com-
monly stated symptoms in the respective category are
listed in table 2. (Respondents gave multiple answers.)
There was a statistically significant difference (P < 0.05)
between the respondents at the HC and DS regarding
knowledge about causes (p = 0.03), but not about symp-
toms (p = 0.12) and danger signs (p = 0.33). The respon-
dents in the HC more frequently (52%) mentioned
microbes as pathogens in diarrhoea than those in the DS
(17%). Staff in the HC was more familiar with signs of de-
hydration both as symptom (68% vs. 30%) and danger sign
(77% vs. 43%) than the staff in DS. At the HC, the fre-
quency of correct and detailed answers increased with the
level of training. For example, 100% of the clinical officers
and nurses mentioned dehydration symptoms while only
Table 1 Causes of diarrhoea as stated by respondents at





Feeding and drinking 24 (77%) 35 (76%)
Contaminated food and feeding practices 20 (65%) 31 (67%)
Contaminated water 13 (42%) 26 (57%)
Malnutrition 8 (26%) 2 (4%)
Weaning/mixing food 5 (16%) 2 (4%)
Hygiene, sanitation and environment 19 (61%) 24 (52%)
Microbes 16 (52%) 8 (17%)
Bacteria 6 (19%) 2 (9%)
Worms 15 (48%) 5 (11%)
Other 3 (16%) -
Other diseases 20 (65%) 25 (54%)
Malaria 20 (65%) 25 (54%)
Measles 7 (23%) 10 (22%)
Other 4 (13%) 3 (7%)
Other causes 5 (16%) 2 (7%)
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mentioned several microbes as causing diarrhea compared
to 75% and 35% of the nurses and nursing assistants
respectively.
Practices in childhood diarrhoea case management
A majority of the respondents at the HC (87%) and the
DS (67%) mentioned ORS as the primary treatment in
childhood diarrhoea, followed by antibiotics (13% at HC,
26% at DS). The most desired stated outcome fromTable 2 Symptoms and danger signs of diarrhoea as stated b
Regular symptoms
Health centre(n = 31) Drug
Dehydration symptoms 68 30
Sunken eyes 26 15
Decreased skin turgor 52 13
Thirst 26 4
Gastrointestinal symptoms 48 33
Loose and frequent stools 35 7
Abdominal discomfort and pain 13 13
Vomiting 10 7
General condition 61 70
Weakness and malaise 32 41
Loss of apetite 19 33
Altered body temperature 16 7
Other symptoms 19 20
Do not know - 7treating diarrhoea was cure or reduction of the fre-
quency of loose stools (42% in HC, 70% in DS). The sec-
ond most wanted outcome was rehydration (39% in the
HC, 20% in the DS). In the HC, better educated staff
was more prone to mention rehydration as the desired
outcome than less educated staff.
When asked about actual practices, 87% (HC) and
70% (DS) mentioned that they gave ORS. 81% (HC) and
87% (DS) stated that they prescribed antibiotics. Anti-
motility drugs were never mentioned in the HC, but by
9% of the respondents in DS. Zinc was never mentioned
as a recommended treatment, neither in HC nor in DS,
but 55% at the HC and 50% at the DS had heard about
the zinc preparation promoted in Uganda. At the time
of the study, zinc was not included in the clinical guide-
lines from the Ministry of Health (MoH) and it was not
provided to the health centres. Differences in practices
between HC and DS were not statistically significant.
The facility inventory showed that 77% of the HC and
63% of the DS had ORS in stock. The stated reason for
stock outs at the HC was delayed delivery from central
medicine depots, and in the DS that the owner had not
ordered ORS. MOH clinical guidelines were available in
68% of the HC and in 4% of the DS.
Record review
In the record review, 523 cases of childhood diarrhoea
were identified. Most cases were diagnosed and treated
for concomitant conditions such as malaria (83%, 95%
Confidence Interval (CI) 80–86) and respiratory tract in-
fection (16%, 95% CI 13–19). Dysentery was uncommon
(2%, 95% CI 1–3). The most commonly recommended
treatments were antimalarials (82%, 95% CI 79–85) andy the respondents at health centres and drug shops (%)
Danger signs
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therapy (78%, 95% CI 74–82), antibiotics (76%, 95% CI
72–80), deworming medicines (32%, 95% CI 29–35),
vitamins and trace elements (16%, 95% CI 13–19) and
other (4%, 95% CI 2–6).
Discussion
Diarrhoeal diseases is a major target in the global efforts
to increase survival and reduce the disease burden in
children [2]. Prevention is of primary importance in
these efforts but adequate management of cases is essen-
tial to reduce mortality, in particular the administration
of Oral Rehydration Solutions (ORS) to treat dehydra-
tion [3]. The findings in this study highlight areas for
improvement in diarrhoea case management.
Respondents’ knowledge about symptoms and danger
signs of dehydration showed positive results but also
that there was room for improvement. Such knowledge
is essential as most deaths from diarrhoea are caused by
dehydration. Staff in HC generally scored better than
those in DS. Further training of staff on diarrhoea, its
symptoms and potential consequences is called for. In
particular, clinic based training with hands-on experi-
ence from treating cases should be considered as it has
proven to be particularly effective [4].
Knowledge on treatment with ORS was generally
good. ORS was the stated first hand treatment choice in
87% of the interviews in the HC and in 67% of the DS.
Equally many (87% respectively 70%) claimed that they
recommend ORS in real practice. In the record review
78% of the cases had been given rehydration therapy.
Still, it was only the third most commonly recom-
mended medicine in childhood diarrhoea. In one third
of the facilities ORS was out of stock.
Overuse of inappropriate medication during childhood
diarrhoea is common [15,16]. Antibiotics are extensively
used in diarrhoea case management [17-19], even
though they are only recommended in few cases of diar-
rhoea. Anti-diarrhoeal medicines are not recommended
at all in children [20-22].
Antibiotics are often attained from other sources than
from trained medical personnel [23]. In the present
study over 80% of the respondents stated they recom-
mend antibiotics. Still, antibiotics are only indicated in
dysentery, cholera and for certain cases of persistent
diarrhea [2,24]. Overuse cause potentially harmful side
effects and contributes to bacterial resistance develop-
ment [25]. In the record review, dysentery was a rare
diagnosis (2%) and it cannot motivate that 76% of the
cases were recommended antibiotics.
Despite the high use of antibiotics, microbes were not
mentioned equally frequent as pathogens in diarrhoea
(52% in HC and 17% in DS). Worms and bacteria were
the most well-known microbes while viral pathogens,that often cause childhood diarrhea [26], were never
mentioned. Improved knowledge about diarrhoea eti-
ology and when to treat with antibiotics, could possibly
decrease the antibiotic usage.
Antidiarrhoeals were never recommended in the HC
and sold in only 9% of the DS, corresponding to a much
lower use rate than that of previous studies [21].
Previous studies have suggested that caretakers may
prefer a combination of ORS and other medicines to sin-
gle therapy with ORS. Zinc has shown to increase ORS
usage [27] and reduce the use of antibiotics and antidiar-
rhoeals [28]. In our study zinc was never used but half
of the respondents had heard about the medicine. A re-
cent study from India showed that, even when available,
zinc is rarely used [29]. Zinc was introduced as standard
treatment in childhood diarrhoea through the WHO/
UNICEF joint statement on the clinical management of
acute diarrhoea in 2004 [10]. However, it is often un-
available in most countries due to difficulties in includ-
ing it in national policy plans or due to lack of funding
[30]. This was also the case in Uganda at the time of the
study. Efforts need to be made to increase the availability
of zinc so that children with diarrhoea can benefit from
the therapy.
Correct management of diseases relies on correct
knowledge on causes, symptoms and therapies. The fre-
quency of correct answers in the interviews increased
with the level of education, but care was often provided
by the least educated personnel. Adequate and continu-
ous training will most likely contribute to improved diar-
rhoea case management. Training within the IMCI
strategy has previously shown to significantly improve
the quality of care for children under five [31].
Drug shops are often the first line of health care in
low-income settings like Namutumba district so it is
crucial to also involve drug shop attendants in training.
Registration and monitoring of DS is needed to reach
this group of health care providers with information and
training opportunities.
We agree with other researchers that “training is not
enough” [31] and other measures must be taken parallel
to knowledge transfer to achieve desired changes in be-
haviour. Still knowledge among providers is a necessary
pre-requisite for large-scale and sustainable improve-
ments in case management.
Most children in the record review were recom-
mended treatment for concomitant diseases. Possibly the
integrated child case management has contributed to
this diagnostic overlap as diagnoses in this setting gener-
ally are based on history and clinical examination. In
reality, cross diagnosing decrease the risk of missing a
case of any of the three potentially life-threatening child-
hood diseases in the study setting (malaria, pneumonia
and diarrhoea). The issue of overlapping symptoms in
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and discussed for pneumonia and malaria [32]. Overlap
issues in diarrhoea have been much less studied and
should be a focus in future research.
Methodological considerations
The results from this provider survey are higher for ORS
prescription than for ORS use as documented in com-
munity household surveys from the area. There are sev-
eral reasons for this discrepancy. One is that some
community members do not seek care from the provi-
ders investigated and their case management is likely to
differ from those who seek a provider′s advice. Another
is that the ORS prescribed may not be bought or little, if
at all, used. Hence, we cannot draw conclusions on com-
munity practices from a survey of providers.
The record reviews at the HC registered the recom-
mended medicines. It was not specified whether the
medicines were given at the facility or had to be pur-
chased elsewhere.
Most drug shops in the district were visited but since
there was no official registration of DS, some DS may
have been missed in the sample. However, it was clear
from interviews that the large majority of drug shops
were identified and included in the study.
The study was carried out in a rural district in Uganda
which limits its generalisability. However, as documen-
ted its findings are in line with findings from other
places.
The principal investigator of the study was performing
the interviews together with an interpreter. This arrange-
ment was selected to improve quality control. However, it
may have increased the risk of over-reporting good prac-
tices. Generally, self-reported practices have lower validity
than other more objective measurements. In this study,
record reviews served as such a measurement. It is a limi-
tation of the study that no such records were available in
drug shops.
Conclusions
The findings show that ORS use is well established but
antibiotics continue to be overprescribed and the zinc
usage is not taking off as it should. A number of inter-
ventions are needed to improve the service delivery.
Continuous training for health care providers in both
HC and DS is a necessary, though not always sufficient,
pre-condition for improved practices. Particular efforts
should be made to increase ORS usage, to introduce zinc
in routine practice and to decrease the significant over-
use of antibiotics. Procurement and logistics around de-
livery of medicines need to be improved so that ORS
and zinc are always in stock in HC and DS. The study
underlines the need for intensified operational research
on implementation of recommended diarrhoea casemanagement as proposed by an international study
group in 2009 [33]. Such research is even more called
for after the recent appeal by President Museveni and
former US President Bill Clinton to accelerate the fight
against diarrhoea in Uganda [34].
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